Capital Analysts LLC’s CareTrust REIT CTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13K Sell
314
-163
-34% -$6.4K ﹤0.01% 1243
2026
Q1
$17K Sell
477
-1
-0.2% -$38 ﹤0.01% 1154
2025
Q4
$17K Buy
478
+91
+24% +$3.26K ﹤0.01% 1136
2025
Q3
$13K Buy
387
+105
+37% +$3.45K ﹤0.01% 1143
2025
Q2
$9K Buy
282
+2
+0.7% +$58 ﹤0.01% 1158
2025
Q1
$8K Buy
+280
New +$7.52K ﹤0.01% 1151

Other funds holding CTRE

Capital Analysts LLC's CTRE Position: Q2 2026 in Review

Capital Analysts LLC reduced its CareTrust REIT (CTRE) stake by 34% in Q2 2026, selling an estimated $6.4K and leaving 314 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Capital Analysts LLC first reported a position in CTRE in Q1 2025 and has held it in 6 quarters since. The position peaked at $17K in Q1 2026. 516 funds tracked by Wall St. Rank hold CTRE as of Q2 2026.

  • Capital Analysts LLC held 314 shares of CareTrust REIT worth $13K as of Q2 2026.
  • Capital Analysts LLC sold 163 CareTrust REIT shares in Q2 2026, an estimated $6.4K.
  • CareTrust REIT made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #1243 holding.
  • Capital Analysts LLC first reported a position in CareTrust REIT in Q1 2025 and has held it in 6 quarters since.
  • Capital Analysts LLC's CareTrust REIT position peaked at $17K in Q1 2026.
  • 516 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.